CITADEL ADVISORS LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Protara Therapeutics, Inc. (TARA)

Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Security
Protara Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares")
Symbol
TARA
Shares outstanding
34.6M shares
Disclosed Ownership
1.63M shares
Ownership
4.7%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 06:24 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 4.6% 1.61M 0 1.61M /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 4.6% 1.61M 0 1.61M /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 4.6% 1.61M 0 1.61M /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0% 15.2K 0 15.2K /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities Group LP 0% 15.2K 0 15.2K /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities GP LLC 0% 15.2K 0 15.2K /s/ Guy Miller Guy Miller, Authorized Signatory
Kenneth Griffin 4.7% 1.63M 0 1.63M /s/ Seth Levy Seth Levy, attorney-in-fact*